🔎 Trials Near Me

Pradžia › Širdies nepakankamumas › Oklahoma

Širdies nepakankamumas klinikiniai tyrimai Oklahoma

17 tyrimai dėl Širdies nepakankamumas ieško dalyvių vietose Oklahoma.

Miestai Oklahoma

Oficialus tyrimo tekstas (anglų kalba)

Early Feasibility Study - Edwards APTURE Transcatheter Shunt System

  • Oklahoma Heart Institute, Tulsa
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT03523416

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  • Research Site, Oklahoma City
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07761117

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

  • Oklahoma State University Center for Health Sciences, Tulsa
Renkami dalyviai3 fazė
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06736574

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • South Oklahoma Heart Research, Oklahoma City
Renkami dalyviai3 fazė
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-16 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  • Research Site, Oklahoma City
  • Research Site, Oklahoma City
Renkami dalyviai3 fazė
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-15 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

  • Bartlesville, OK Investigative Site 10095, Bartlesville
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-10 · NCT06008197

Pedal Pump Clinical Trial on Edema V2

  • Hillcrest Medical Center, Tulsa
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07809516

NORM-HF Pivotal Study

  • Saint Francis Health System, Tulsa
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-25 · NCT07574593

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

  • Oklahoma Cardiovascular Research Group, Oklahoma City
Renkami dalyviai
Amžius 21 ir vyresni · Visoms lytims · Atnaujinta 2026-08-25 · NCT05677100

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

  • Oklahoma City
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-08-20 · NCT00271180

Alleviant ALLAY-HF Study

  • South Oklahoma Heart Research, LLC., Oklahoma City
Renkami dalyviai
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-08-14 · NCT05685303

Pedal Pump Clinical Trial on Edema V1

  • Hillcrest Medical Center, Tulsa
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-12 · NCT07760363

Assessment of CCM in HF With Higher Ejection Fraction

  • Oklahoma Heart Institute, Tulsa
  • St. Francis Hospital - Tulsa, Tulsa
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-06 · NCT05064709

Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure

  • Saint Francis Hospital, Tulsa
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-30 · NCT06552637

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  • Integris Baptist Medical Center, Oklahoma City
  • Oklahoma Heart Institute at Utica, Tulsa
  • Saint Francis Hospital, Tulsa
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-10 · NCT06526195

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

  • Oklahoma Heart Institute Hospital, Tulsa
  • Saint Francis Hospital,, Tulsa
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-13 · NCT03142152

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.